-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MpdYoQL/uGt7V73IPQAc9wjUu4kZKNr2327/QqBhlQ+uvbcEx3eR0Kt54KxTwWn4 cu0buxkPz+93YxtD83MByA== 0001104659-06-073612.txt : 20061109 0001104659-06-073612.hdr.sgml : 20061109 20061109161128 ACCESSION NUMBER: 0001104659-06-073612 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20061108 FILED AS OF DATE: 20061109 DATE AS OF CHANGE: 20061109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANIKA THERAPEUTICS INC CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 6179326616 MAIL ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Garrison Constance H CENTRAL INDEX KEY: 0001379351 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 061202329 BUSINESS ADDRESS: BUSINESS PHONE: 781-932-6616 MAIL ADDRESS: STREET 1: C/O ANIKA THERAPEUTICS, INC. STREET 2: 160 NEW BOSTON STREET CITY: WOBURN STATE: MA ZIP: 01801 3 1 a3.xml 3 X0202 3 2006-11-08 1 0000898437 ANIKA THERAPEUTICS INC ANIK 0001379351 Garrison Constance H 160 NEW BOSTON STREET WOBURN MA 01801 0 1 0 0 V.P.Reg.,Clinical & Qlty.Sys. N/A /s/ Constance H. Garrison 2006-11-09 EX-24 2 ex-24.htm EX-24

Exhibit 24

 

LIMITED POWER OF ATTORNEY

FOR

ANIKA THERAPEUTICS, INC.

SECTION 16(a) FILINGS

 

Know all by these presents, that the undersigned hereby constitutes and appoints each of Charles H. Sherwood and Kevin Q. Quinlan, signing singly, the undersigned’s true and lawful attorney-in-fact to:

 

(1)                                  Execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director and/or stockholder of Anika Therapeutics, Inc. (the “Company”), Forms 3, 4, and 5 and amendments thereto in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 

(2)                                  Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, 4, or 5 or amendments thereto and timely file such forms with the United States Securities and Exchange Commission (the “SEC”) and any stock exchange or similar authority; and

 

(3)                                  Take any other action of any type whatsoever which, in the opinion of such attorney-in-fact, may be necessary or desirable in connection with the foregoing authority, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.  The foregoing attorneys-in-fact may rely on information provided by the undersigned or his representatives and shall not be required to inquire or verify the accuracy thereof.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.  This Power of Attorney may be filed with the SEC as a confirming statement of the authority granted herein.

 



 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 8th day of November, 2006.

 

 

/s/ Constance H. Garrison

 

 


-----END PRIVACY-ENHANCED MESSAGE-----